» Articles » PMID: 18323271

Cytologic Detection of Esophageal Squamous Cell Carcinoma and Its Precursor Lesions Using Balloon Samplers and Liquid-based Cytology in Asymptomatic Adults in Llinxian, China

Overview
Journal Acta Cytol
Publisher Karger
Specialty Cell Biology
Date 2008 Mar 8
PMID 18323271
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Esophageal squamous cell carcinoma (ESCC) is associated with very high regional mortality rates in several countries. Our initial test of esophageal cytology screening devices found them not sensitive enough for an early detection program. The current study tested a newly designed "mechanical" balloon and a traditional Chinese inflatable balloon, followed by liquid-based cytology, to detect biopsy-proven squamous dysplasia and early cancer.

Study Design: Participants were randomized to a cytologic sampler, followed by endoscopy with iodine staining. For each patient, the cytologic diagnosis (test) was compared with the worst endoscopic biopsy diagnosis (truth).

Results: Seven hundred forty subjects completed both examinations. Approximately 30% showed atypical squamous cells of undetermined significance (ASCUS), and 10% showed squamous intraepithelial lesions. Seven hundred twenty-five subjects (98%) had satisfactory biopsies, and 32% had low grade dysplasia or worse disease. Defining > ASCUS, favor neoplastic, as a positive screening test, the sensitivities/specificities of the mechanical and inflatable balloons were 39%/85% and 46%/84%, respectively, for detecting any squamous dysplasia or cancer.

Conclusion: These esophageal cell samplers performed equivalently, but the accuracy was still too low for a primary screening test. These results highlight the need to develop new cytologic criteria or molecular markers that can better detect early squamous esophageal disease [corrected]

Citing Articles

Application of Esophageal Sponge Cytology in Screening Esophageal Squamous Cell Carcinoma in a High-Risk Region of China.

Huang S, Gu X, Zhou H, Feng Y, Shi R, Wang W Cancer Med. 2025; 14(3):e70467.

PMID: 39856802 PMC: 11761409. DOI: 10.1002/cam4.70467.


Artificial intelligence enhances the management of esophageal squamous cell carcinoma in the precision oncology era.

Zhang W, Chang Y, Shi R World J Gastroenterol. 2024; 30(39):4267-4280.

PMID: 39492825 PMC: 11525855. DOI: 10.3748/wjg.v30.i39.4267.


Genome-wide methylation profiling identify hypermethylated HOXL subclass genes as potential markers for esophageal squamous cell carcinoma detection.

Yu Q, Xia N, Zhao Y, Jin H, Chen R, Ye F BMC Med Genomics. 2022; 15(1):247.

PMID: 36447287 PMC: 9706897. DOI: 10.1186/s12920-022-01401-x.


Study protocol for artificial intelligence-assisted sponge cytology as pre-endoscopy screening for early esophegeal squmaous epithelial lesions in China.

Feng Y, Wang B, Pan L, Yao B, Deng B, Liang Y BMC Cancer. 2022; 22(1):1105.

PMID: 36307758 PMC: 9617337. DOI: 10.1186/s12885-022-10220-3.


Artificial intelligence assisted cytological detection for early esophageal squamous epithelial lesions by using low-grade squamous intraepithelial lesion as diagnostic threshold.

Yao B, Feng Y, Zhao K, Liang Y, Huang P, Zang J Cancer Med. 2022; 12(2):1228-1236.

PMID: 35766144 PMC: 9883535. DOI: 10.1002/cam4.4984.